This white paper highlights the growing significance of advanced Key Account Management (KAM) strategies in the pharma and medtech sectors, driven by healthcare system consolidation, increased administrative control, and higher expectations for manufacturer partnerships. Despite recent progress, few companies effectively deliver tailored solutions at scale, marking a crucial area for development. The paper argues that evolving B2B marketing capabilities is essential for realizing the potential of advanced KAM, offering a detailed framework for B2B marketing's role in delivering tailored solutions and fostering strategic partnerships.

Join for free to read